D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$625M |
| 3 |
Merck
MRK
|
$498M |
| 4 |
Bank of America
BAC
|
$487M |
| 5 |
Fortinet
FTNT
|
$321M |
Top Sells
| 1 |
Tesla
TSLA
|
$696M |
| 2 |
Adobe
ADBE
|
$610M |
| 3 |
Accenture
ACN
|
$518M |
| 4 |
Microsoft
MSFT
|
$495M |
| 5 |
Broadcom
AVGO
|
$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Liberty Live Group Series C
LLYVK
$8.88B
| $78.3M | 0.07% |
1,526,152
+122,133
| +9% | +$6.27M |
|
|
HCP
202
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $78.2M | 0.07% |
2,309,212
+1,208,221
| +110% | +$40.9M |
|
203
Uber
UBER
$190B
| $77.8M | 0.07% |
1,035,319
-3,916,008
| -79% | -$294M |
|
204
Zoom
ZM
$25B
| $77.6M | 0.07% |
1,112,762
+564,031
| +103% | +$39.3M |
|
205
Hexcel
HXL
$5.16B
| $76.9M | 0.07% |
1,243,945
+378,710
| +44% | +$23.4M |
|
206
Dell
DELL
$84.4B
| $76.6M | 0.07% |
646,196
+304,142
| +89% | +$36.1M |
|
207
QuidelOrtho
QDEL
$1.95B
| $76.5M | 0.07% |
1,677,838
+121,194
| +8% | +$5.53M |
|
208
iShares Core S&P 500 ETF
IVV
$664B
| $75.1M | 0.06% |
+130,128
| New | +$75.1M |
|
209
Novavax
NVAX
$1.28B
| $75M | 0.06% |
5,937,165
-384,910
| -6% | -$4.86M |
|
210
Credo Technology Group
CRDO
$24.4B
| $74.8M | 0.06% |
2,428,477
-2,956
| -0.1% | -$91K |
|
211
Abercrombie & Fitch
ANF
$4.49B
| $74.7M | 0.06% |
533,733
-934,999
| -64% | -$131M |
|
212
STMicroelectronics
STM
$24B
| $73.6M | 0.06% |
2,476,242
+30,403
| +1% | +$904K |
|
213
EPAM Systems
EPAM
$9.44B
| $73.5M | 0.06% |
369,432
+8,882
| +2% | +$1.77M |
|
214
IQVIA
IQV
$31.9B
| $73.5M | 0.06% |
310,149
+41,597
| +15% | +$9.86M |
|
215
Incyte
INCY
$16.9B
| $73.3M | 0.06% |
1,108,573
-124,644
| -10% | -$8.24M |
|
216
Bilibili
BILI
$9.25B
| $73.2M | 0.06% |
3,132,715
+2,450,983
| +360% | +$57.3M |
|
217
Starbucks
SBUX
$97.1B
| $72.6M | 0.06% |
744,537
-1,350,951
| -64% | -$132M |
|
218
Kroger
KR
$44.8B
| $72.4M | 0.06% |
1,263,588
+268,913
| +27% | +$15.4M |
|
219
Exxon Mobil
XOM
$466B
| $71.8M | 0.06% |
612,937
-693,786
| -53% | -$81.3M |
|
220
Vulcan Materials
VMC
$39B
| $71.8M | 0.06% |
286,514
+200,551
| +233% | +$50.2M |
|
221
Morgan Stanley
MS
$236B
| $71.1M | 0.06% |
682,270
-784,497
| -53% | -$81.8M |
|
222
Intuitive Surgical
ISRG
$167B
| $70.6M | 0.06% |
143,729
+107,044
| +292% | +$52.6M |
|
223
Medpace
MEDP
$13.7B
| $69.6M | 0.06% |
208,541
-91,324
| -30% | -$30.5M |
|
224
PepsiCo
PEP
$200B
| $69.5M | 0.06% |
408,426
-76,196
| -16% | -$13M |
|
225
ARK Innovation ETF
ARKK
$7.49B
| $69.3M | 0.06% |
1,457,196
+42,483
| +3% | +$2.02M |
|